David Limsui, M.D.

David G. Mohler, MD, is a highly regarded orthopaedic surgical oncologist specializing in musculoskeletal tumors and sarcomas. With extensive education and training, including a fellowship at Memorial Sloan Kettering Cancer Center, he holds a clinical professorship at Stanford Medicine Orthopaedics & Sports Medicine. Dr. Mohler's expertise encompasses a range of treatments for bone and cartilage tumors, and he has contributed significantly to medical literature in the field. His dedication to advancing surgical techniques and improving patient outcomes is reflected in multiple honors, including the Saul Halpern MD Orthopaedic Educator Award from Stanford University School of Medicine. Generated from the website

Stanford's Orthopaedic Surgical Oncology Program is globally recognized for its innovative surgical techniques and success in treating complex cancer cases and orthopedic problems. The program specializes in a variety of conditions, including chondrosarcoma, osteosarcoma, and avascular necrosis, providing comprehensive care tailored to each patient's needs. In addition to advanced treatment options, the program offers access to cutting-edge clinical trials, allowing patients to participate in research studies evaluating new medical approaches. With a commitment to quality and safety, the Orthopaedic Surgical Oncology Program aims to deliver exceptional care and improve patient outcomes. Generated from the website

Dr. Sunwoo was born and raised in St. Louis, Missouri. He received his undergraduate degree from Brown University in Providence, Rhode Island and his medical degree from Washington University in St. Louis, Missouri. He completed his training in Otolaryngology Head and Neck Surgery at Washington University. Dr. Sunwoo has been at Stanford University since 2008, and his clinical focus is on the surgical management of head and neck cancer, specifically focusing on melanoma and neoplasms of the thyroid and parathyroid glands. He is a member of the Pigmented Lesions and Melanoma Clinic and the Melanoma Working Group at Stanford. He is also the co-founder of the Stanford Thyroid and Parathyroid Tumor Board.In addition to his clinical work, Dr.